Company logo

EVFM - Evofem Biosciences, Inc.

NASDAQ -> Healthcare -> Biotechnology
San Diego, United States
Type: Equity

EVFM price evolution
EVFM
(in millions $) 31 Mar 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Current assets
Cash $1.53 $3.98 $9.04 $21.47
Short term investments
Net receivables $7.4 $1.13 $12.76 $7.3
Inventory $5.48 $5.38 $5.18 $5.95
Total current assets $16.51 $12.7 $31.79 $41.91
Long term investments
Property, plant & equipment $7.6 $8.35 $9.38 $10.34
Goodwill & intangible assets
Total noncurrent assets $9.52 $12.46 $10.49 $11.57
Total investments
Total assets $26.03 $25.16 $42.28 $53.47
Current liabilities
Accounts payable $18.8 $14.98 $14.54 $15.39
Deferred revenue
Short long term debt $52.87 $68 $80.13 $121.83
Total current liabilities $79.81 $93.83 $116.71 $265.56
Long term debt $2.63 $3.13 $3.62 $3.91
Total noncurrent liabilities $2.63 $3.13 $3.62 $3.91
Total debt $55.49 $71.13 $83.75 $125.74
Total liabilities $82.44 $96.96 $120.33 $269.47
Shareholders' equity
Retained earnings -$941.05 -$938.69 -$930.36 -$1019.86
Other shareholder equity $64.99 $49.53 $36.96 $1.59
Total shareholder equity -$56.4 -$71.8 -$78.04 -$216
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $3.98 $12.79 $71.45 $15.88
Short term investments $8.23
Net receivables $1.13 $6.45 $1.07 $0.7
Inventory $5.38 $7.67 $7.16
Total current assets $12.7 $30.14 $97.73 $26.42
Long term investments
Property, plant & equipment $8.35 $11.17 $11.19 $0.55
Goodwill & intangible assets
Total noncurrent assets $12.46 $12.37 $12.24 $1.87
Total investments $8.23
Total assets $25.16 $42.51 $109.97 $28.3
Current liabilities
Accounts payable $14.98 $10.32 $10.64 $6.01
Deferred revenue
Short long term debt $68 $111.26 $54.7 $0.2
Total current liabilities $93.83 $137.66 $77.28 $12.66
Long term debt $3.13 $4.42 $31.24
Total noncurrent liabilities $3.13 $4.42 $31.34
Total debt $71.13 $115.68 $85.94 $0.2
Total liabilities $96.96 $142.09 $108.62 $12.66
Shareholders' equity
Retained earnings -$938.69 -$860.68 -$655.49 -$513.18
Other shareholder equity $49.53 $5.09
Total shareholder equity -$71.8 -$104.31 $1.35 $15.64
(in millions $) 31 Mar 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Revenue
Total revenue $5.81 $0.18 $6.37 $6.03
Cost of revenue $1.38 $0.38 $1.68 $1.28
Gross Profit $4.43 -$0.2 $4.69 $4.75
Operating activities
Research & development $0.54 $1.69 $5.21 $7.74
Selling, general & administrative $7.47 $10.16 $18.21 $21.42
Total operating expenses $8.01 $11.85 $23.41 $29.17
Operating income -$3.58 -$12.05 -$18.72 -$24.42
Income from continuing operations
EBIT -$2.35 -$8.33 $89.52 -$125.96
Income tax expense $0 $0.01 $0.01 $0.02
Interest expense
Net income
Net income -$2.35 -$8.34 $89.51 -$125.98
Income (for common shares) -$2.35 -$11.48 $89.51 -$124.07
(in millions $) 31 Dec 2022 31 Jan 2022 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $16.84 $0.45
Cost of revenue $4.42 $0.47
Gross Profit $12.42 -$0.02
Operating activities
Research & development $25.03 $17.05 $22.23
Selling, general & administrative $71.51 $86.55 $30.51
Total operating expenses $96.55 $103.6 $52.74
Operating income -$84.12 -$103.62 -$52.74
Income from continuing operations
EBIT -$76.65 -$142.31 -$80.03
Income tax expense $0.04 $0 $0
Interest expense
Net income
Net income -$76.7 -$142.31 -$80.03
Income (for common shares) -$78.01 -$142.31 -$80.03
(in millions $) 31 Mar 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Net income -$2.35 -$8.34 $89.51 -$125.98
Operating activities
Depreciation $0.24 $0.25 $0.25 $0.25
Business acquisitions & disposals
Stock-based compensation $0.42 $0.18 $0.98 $1.08
Total cash flows from operations -$4.94 -$6.53 -$16.3 -$26.66
Investing activities
Capital expenditures -$0 -$0.04 -$0.07 -$0.17
Investments
Total cash flows from investing -$0 -$0.04 -$0.07 -$0.17
Financing activities
Dividends paid
Sale and purchase of stock $0.06 $4.29 $47.76
Net borrowings $1.64 $1.5 -$5.89
Total cash flows from financing $1.7 $1.5 $3.95 $41.36
Effect of exchange rate
Change in cash and equivalents -$3.24 -$5.07 -$12.42 $14.53
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$76.7 -$205.19 -$142.31 -$80.03
Operating activities
Depreciation $1.01 $1.02 $0.3 $0.26
Business acquisitions & disposals $0.25 $0.25 $0.25
Stock-based compensation $3.31 $8.9 $12.7 $8.58
Total cash flows from operations -$70.41 -$146.67 -$104.83 -$55.1
Investing activities
Capital expenditures -$0.34 -$2.94 -$2.25 -$0.13
Investments $8.23 -$8.23
Total cash flows from investing -$0.34 -$2.69 $6.23 -$8.12
Financing activities
Dividends paid
Sale and purchase of stock $57.53 $81.99 $107.97 $84.94
Net borrowings $5.61 $48.94 -$4.01
Total cash flows from financing $61.94 $90.69 $154.23 $78.08
Effect of exchange rate
Change in cash and equivalents -$8.81 -$58.66 $55.63 $14.86
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $18.39M
EBITDA -$46.13M
EBIT -$47.12M
Net Income -$47.16M
Revenue Q/Q 36.65%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA -128.38%
ROE 44.68%
Debt/Equity -1.35
Net debt/EBITDA -1.75
Current ratio 0.21
Quick ratio 0.14